WebCiclofilin Pharmaceuticals Inc. Overview. Ciclofilin Pharmaceuticals Inc. filed as an Articles of Incorporation in the State of California and is no longer active.This corporate entity was filed approximately nine years ago on Monday, January 13, 2014 , according to public records filed with California Secretary of State. WebRecently, he was President and co-founder of Ciclofilin Pharmaceuticals, a San Diego based-biotechnology company, which was sold to ContraVir Pharmaceuticals. During his career, he has worked on various roles in Buy-side and Sell-Side Institutions, including Difference Capital Financial Inc., and GMP Securities Inc. in Canada.
RaisedToday.com
WebMay 31, 2016 · CPI-431-32 is a highly potent derivative of cyclosporine, yet is engineered to be non-immunosuppressive. It selectively targets and inhibits host cellular enzymes … WebGary S. Jacob, Ph.D. Gary S. Jacob, Ph.D., has served as our Chairman of the Board of Directors since March 19, 2014, and earlier served as our Chief Executive Officer from May 15, 2013 until March 19, 2014. Since January 2024, Dr. Jacob has been Chief Executive Officer and a director of OKYO Pharma Limited, a biotechnology company focused on ... interviewunit examone.com
ballbap - Blog
WebCiclofilin Pharmaceuticals is a biopharmaceutical company specializing in development of cyclophilin inhibitors. UPM Pharmaceuticals, Inc. and Ciclofilin Pharmaceuticals share similar industries . Save These companies are similar. Show More . Unlock even more features with Crunchbase Pro . WebOct 27, 2014 · SAN DIEGO, Oct. 27, 2014 (GLOBE NEWSWIRE) -- Ciclofilin Pharmaceuticals Inc. ("Ciclofilin" or the "Company"), a developer of broad spectrum antiviral medications, announced today the appointment of Stephen F. Keane as Senior Vice President of Corporate Development. In this role, Mr. Keane will be responsible for … new haven ct pet friendly bed and breakfast